Expression of luminal and basal cytokeratins in human breast carcinoma
By Dalia M. Abd El‐Rehim, Sarah E. Pinder, C. Paish, J. Bell, Roger W. Blamey, J. Robertson, R. Nicholson, Ian O. Ellis. Journal of Pathology, 2004
615 citations recorded by the source corpus.
Subfields: Cancer Research, Dermatology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/a0bb04c6fd5ef21b5655e1e97a952b52d60a6126
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Dermatology
In Pathology and Forensic Medicine
Citations in the corpus
- Prognostic markers in triple‐negative breast cancer (2007, background): “This is a well-characterized series of primary breast carcinoma with a long-term follow-up that has been treated in a uniform way and previously used to study a wide range of biomarkers.(17,18) Patient’s clinical history and tumor characteristics were assessed in a uniform fashion.”
- Triple negative tumours: a critical review (2007, background): “Basal-like cancers, as defined by microarrays or by immunohistochemical surrogates, have been shown to have a more aggressive clinical behaviour.(10,42,43) In fact, some studies have demonstrated that expression of basal keratins is a prognostic factor independent of tumour size, grade and lymph nod”
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. (2006, neutral): “…3A] and the other as basal-like [ESR1-negative, CAV1-positive, (iii) in Figure 3A; Jones et al., 2004] using published gene markers of in vivo histology (Abd El-Rehim et al., 2004; Cattoretti et al., 1988; Jones et al., 2004; Korsching et al., 2002; Nielsen et al., 2004; Simpson et al., 2004).”
- X chromosomal abnormalities in basal-like human breast cancer. (2006, background): “…invasive ductal carcinomas that do not express estrogen receptor (ER), progesterone receptor (PR), or HER2; display a high incidence of p53 mutations; and express specific cytokeratins characteristic of the basal layer of breast epithelium (Abd El-Rehim et al., 2004; Palacios et al., 2005).”